Half-year report · Q2
2413.TEDINET S100UO9S
Period2024-04-01 → 2024-09-30
Filed2024-11-08
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥124.8bn | 2024-04-01 → 2024-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥238.9bn | 2023-04-01 → 2024-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥115.8bn | 2023-04-01 → 2023-09-30 | Cons. | Revenue IFRS |
| Operating income | ¥29.0bn | 2024-04-01 → 2024-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥34.6bn | 2023-04-01 → 2023-09-30 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥29.1bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥68.8bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥37.3bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥17.3bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥45.3bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥23.4bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥19.6bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥25.1bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss IFRS |
| Total assets | ¥491.5bn | at 2024-09-30 | Cons. | Assets IFRS |
| Total assets | ¥490.8bn | at 2024-03-31 | Cons. | Assets IFRS |
| Total assets | ¥461.0bn | at 2023-09-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥127.0bn | at 2024-09-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥124.1bn | at 2024-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥364.4bn | at 2024-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥366.7bn | at 2024-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥345.2bn | at 2023-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥309.5bn | at 2023-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥349.5bn | at 2024-09-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥351.9bn | at 2024-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥331.6bn | at 2023-09-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥148.1bn | at 2024-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥149.7bn | at 2024-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥135.1bn | at 2023-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥118.3bn | at 2023-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥23.6bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥58.3bn | 2023-04-01 → 2024-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥26.8bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥11.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥39.5bn | 2023-04-01 → 2024-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥28.3bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥12.6bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥9.4bn | 2023-04-01 → 2024-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥15.3bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥25.47 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥66.68 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥34.47 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥25.4 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥66.63 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥34.45 | 2023-04-01 → 2023-09-30 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 71.1% | at 2024-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 71.7% | at 2024-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 71.9% | at 2023-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 54
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥1.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥1.9bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥1.7bn |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥11.6bn |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥11.6bn |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥18m |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥4.1bn |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥11.9bn |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥11.8bn |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥100m |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥42.5bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥40.7bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥14.6bn |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥38.0bn |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥38.0bn |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥28m |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥6.6bn |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥21.6bn |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥21.6bn |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥6m |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥125.6bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥123.7bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥30.3bn |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥1.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥1.8bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | ¥125m |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥9.0bn |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥9.0bn |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥21m |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥3.3bn |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥13.8bn |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥13.6bn |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥215m |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥3.6bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥45.5bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥44.0bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥1.5bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥18.4bn |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥32.7bn |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥32.6bn |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥11m |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥7.3bn |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥15.3bn |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥15.3bn |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥7m |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥1.8bn |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥116.4bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥114.6bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥1.7bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥34.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 642
| Item | Context | Value | Unit |
|---|---|---|---|
| Filer name in english | FilingDateInstant | M3, Inc. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | IFRS | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2024-04-01 | |
| Current period end date | FilingDateInstant | 2024-09-30 | |
| Type of current period | FilingDateInstant | Q2 | |
| Current fiscal year end date | FilingDateInstant | 2025-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2023-04-01 | |
| Comparative period end date | FilingDateInstant | 2023-09-30 | |
| Previous fiscal year end date | FilingDateInstant | 2024-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所プライム市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)単元株式数100株 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | CurrentQuarterInstant_No1MajorShareholdersMember | Original text (Japanese)ソニーグループ株式会社 | |
| Address major shareholders | CurrentQuarterInstant_No1MajorShareholdersMember | Original text (Japanese)東京都港区港南１丁目７番１号 | |
| Name major shareholders | CurrentQuarterInstant_No2MajorShareholdersMember | Original text (Japanese)日本マスタートラスト信託銀行株式会社 | |
| Address major shareholders | CurrentQuarterInstant_No2MajorShareholdersMember | Original text (Japanese)東京都港区赤坂１丁目８番１号赤坂インターシティAIR | |
| Name major shareholders | CurrentQuarterInstant_No3MajorShareholdersMember | Original text (Japanese)株式会社日本カストディ銀行 | |
| Address major shareholders | CurrentQuarterInstant_No3MajorShareholdersMember | Original text (Japanese)東京都中央区晴海１丁目８番12号 | |
| Name major shareholders | CurrentQuarterInstant_No4MajorShareholdersMember | Original text (Japanese)株式会社ＮＴＴドコモ | |
| Address major shareholders | CurrentQuarterInstant_No4MajorShareholdersMember | Original text (Japanese)東京都千代田区永田町２丁目11番１号 | |
| Name major shareholders | CurrentQuarterInstant_No5MajorShareholdersMember | Original text (Japanese)谷村 格 | |
| Address major shareholders | CurrentQuarterInstant_No5MajorShareholdersMember | Original text (Japanese)東京都港区 | |
| Name major shareholders | CurrentQuarterInstant_No6MajorShareholdersMember | Original text (Japanese)STATE STREET BANK AND TRUST COMPANY 505223（常任代理人 株式会社みずほ銀行） | |
| Address major shareholders | CurrentQuarterInstant_No6MajorShareholdersMember | Text · Plus | |
| Name major shareholders | CurrentQuarterInstant_No7MajorShareholdersMember | Original text (Japanese)STATE STREET BANK AND TRUST COMPANY 505001（常任代理人 株式会社みずほ銀行） |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |